NF-κB in biology and targeted therapy: new insights and translational implications

Q Guo, Y **, X Chen, X Ye, X Shen, M Lin… - Signal transduction and …, 2024 - nature.com
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was
identified as a pivotal pathway in mediating inflammatory responses. However, with …

[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives

H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced drug delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …

Poly(l‐Histidine)‐Mediated On‐Demand Therapeutic Delivery of Roughened Ceria Nanocages for Treatment of Chemical Eye Injury

CJ Yang, DD Nguyen, JY Lai - Advanced Science, 2023 - Wiley Online Library
Abstract Development of topical bioactive formulations capable of overcoming the low
bioavailability of conventional eye drops is critically important for efficient management of …

[HTML][HTML] Role and mechanisms of the NF-ĸB signaling pathway in various developmental processes

P Liu, Y Li, W Wang, Y Bai, H Jia, Z Yuan… - Biomedicine & …, 2022 - Elsevier
Since the discovery of the nuclear factor kappa B (NF-ĸB) transcription factor 36 years ago,
many studies have linked the NF-ĸB signaling pathway to pathological and physiological …

Current and emerging therapies for corneal neovascularization

D Roshandel, M Eslani, A Baradaran-Rafii… - The ocular …, 2018 - Elsevier
The cornea is unique because of its complete avascularity. Corneal neovascularization
(CNV) can result from a variety of etiologies including contact lens wear; corneal infections; …

[HTML][HTML] Up-to-date molecular medicine strategies for management of ocular surface neovascularization

Y Yang, J Zhong, D Cui, LD Jensen - Advanced Drug Delivery Reviews, 2023 - Elsevier
Ocular surface neovascularization and its resulting pathological changes significantly alter
corneal refraction and obstruct the light path to the retina, and hence is a major cause of …

Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics

D Datta, SP Bandi, V Colaco, N Dhas… - International Journal of …, 2024 - Elsevier
Ocular delivery is the most challenging aspect in the field of pharmaceutical research. The
major hurdle for the controlled delivery of drugs to the eye includes the physiological static …

Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB

Z Huang, T Mou, Y Luo, X Pu, J Pu, L Wan… - Cell Death & …, 2020 - nature.com
Hepatic ischemia/reperfusion injury (IRI) is an unavoidable course in liver transplantation,
during which the immune response of inflammation plays a leading part. MicroRNA-450b-5p …

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway

S Kumar, A Nandi, S Singh, R Regulapati, N Li… - Nature …, 2021 - nature.com
Abstract Development of chemoresistance in breast cancer patients greatly increases
mortality. Thus, understanding mechanisms underlying breast cancer resistance to …

Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core–shell nanoparticles for enhanced tumor-localized …

T Wang, J Zhang, T Hou, X Yin, N Zhang - Nanoscale, 2019 - pubs.rsc.org
Tumor associated macrophage (TAM)-based immunotherapy has been presented as a
promising strategy in cancer therapy. The combination of TAM-based immunotherapy with …